The co-occurrence of TERT promoter mutations and BRAF-like mutations indicates an extremely high risk of thyroid cancer and is associated with increased extrathyroidal spread and lymph node metastasis risk. This evidence concerns the gene TERT and thyroid gland carcinoma.